--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About ARMP20260220P5
Biological Technology
Armata Pharmaceuticals, Inc., was established under Washington state law in March 1989 as a wholly-owned subsidiary of Immunex Corporation and began operations in 1992 as an independent targeted genetics company. The company is a clinical-stage biotechnology company focused on developing pathogen-specific phage therapies for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary phage-based technologies.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
